Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies

Leukemia Research

Volumn 36, Issue 3, 2012, Pages

  Brezinova, Jana ^a   Zemanova, Zuzana ^b   Bystricka, Dagmar ^b   Sarova, Iveta ^a   Lizcova, Libuse ^b   Malinova, Eva ^b   Izakova, Silvia ^b   Sajdova, Jana ^a   Sponerova, Dana ^b   Jonasova, Anna ^b   Cermak, Jaroslav ^a   Michalova, Kyra ^b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ERYTHROPOIETIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME DELETION 5; CHROMOSOME DELETION 5Q31; CYTOGENETICS; ERYTHROCYTE COUNT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIESIS; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; LETTER; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MONOCYTE; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 84855977648     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.11.007     Document Type: Letter

References (10)

1. Eisenmann K.M., Dykema K.J., Matheson S.F., Kent N.F., DeWard A.D., West R.A., et al. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. Oncogene 2009, 28(39):3429-3441.
2. Boultwood J., Pellagatti A., McKenzie A.N., Wainscoat J.S. Advances in the 5q-syndrome. Blood 2010, 116(26):5803-5811.
3. Jädersten M., Hellström-Lindberg E. New clues to the molecular pathogenesis of myelodysplastic syndromes. Exp Cell Res 2010, 316(8):1390-1396.
4. Heim S., Mitelman F. Cancer cytogenetics 1995, Wiley-Liss, New York. 2nd ed.
5. Royer-Pokora B., Trost D., Müller N., Hildebrandt B., Germing U., Beier M. Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia. Cancer Genet Cytogenet 2006, 167(May (1)):66-69.
6. Douet-Guilbert N., Basinko A., Eveillard J.R., Morel F., Le Bris M.J., Guéganic N., et al. Three rearrangements of chromosome 5 in a patient with myelodysplastic syndrome: an atypical deletion 5q, a complex intrachromosomal rearrangement of chromosome 5, and a paracentric inversion of chromosome 5. Cancer Genet Cytogenet 2010, 203(2):303-308.
7. Boultwood J., Pellagatti A., Cattan H., Lawrie C.H., Giagounidis A., Malcovati L., et al. Gene expression profiling of CD34+ cells in patients with the 5q-syndrome. Br J Haematol 2007, 139(4):578-589.
8. Itzhar N., Dessen P., Toujani S., Auger N., Preudhomme C., Richon C., et al. Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. PLoS One 2011, 6(February 14 (2)):e16623.
9. Stockwin L.H., Vistica D.T., Kenney S., Schrump D.S., Butcher D.O., Raffeld M., et al. Gene expression profiling of alveolar soft-part sarcoma (ASPS). BMC Cancer 2009, 9(January 15):22.
10. Hernández D., Docampo M.J., Bassols A. VCAN (versican). Atlas Genet Cytogenet Oncol Haematol 2010, (October). http://atlasgeneticsoncology.org/Genes/VCANID40173ch5q14.html.